NovaBay Pharmaceuticals Inc.

11/26/2025 | Press release | Archived content

Notice of Effectiveness (Form EFFECT)

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: November 26, 2025 5:00 P.M.
Form: S-3
CIK: 0001389545
Company Name: NovaBay Pharmaceuticals, Inc.
File Number: 333-290712
NovaBay Pharmaceuticals Inc. published this content on November 26, 2025, and is solely responsible for the information contained herein. Distributed via EDGAR on November 28, 2025 at 11:05 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]